Biotechnology
Breaking News
Healthcare
Investing News
Market News
Technology
The Buzz
The Buzz TV
The Market Buzz
Top Videos
Video
“The Buzz” Show: Aditxt (NASDAQ: ADTX) Toxicity Study Psoriasis Drug Candidate ADI™-100
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Aditxt, Inc. Successfully Completes Preclinical Toxicity Study of Its Psoriasis Drug Candidate ADI™-100” Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt”...